October marked a respite from the heavy declines of September for the portfolio. However, this wasn't without some big swings in both directions. It certainly seems as if continued volatility is here to stay, and the rotation away from high growth names toward more value-based names is also in progress. October saw a net gain of just under 3%, compared to the growth in the index of 2.1%, with Project $1M outperforming by almost 0.8%. While October saw outperformance, I don't view any near-term underperformance that may occur in the portfolio as a negative. In